Related Experiment Video
Updated: Dec 9, 2025

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
Modafinil ameliorated pancreatic injury and inflammation through upregulating SNIP1
Jianwu Wu1, Yijie Lu1, Ancheng Qin1
1Department of Hepatobiliary and Pancreatic Surgery, Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu, China.
Abstract:
Acute pancreatitis (AP) is the inflammatory response of the exocrine pancreas to various causes. Modafinil has significant anti-inflammation and anti-oxidation effects. No experiment has assessed the effects of modafinil on AP. Thus, the study aims to study the effects of modafinil on AP and its potential mechanism in vivo and vitro. 5% sodium taurocholate was retrograde injected into pancreatic duct to establish AP rat model. The severity of AP was detected by HE staining, serum amylase and lipase levels. The inflammation, oxidative stress and apoptosis were detected separately by ELISA, MDA and SOD kits, tunnel staining and Western blotting in rats. Besides, SNIP1 expression was analyzed by qPCR and Western blotting. In vivo, AR42J cells were stimulated by cerulein and lipopolysaccharide to establish AP cell model. Flow cytometry examined cell apoptosis. After the plasmids silencing SNIP1 were transfected into AP cells, the inhibitory effects of modafinil on inflammation, oxidative stress and apoptosis were significantly reversed. The results indicated that modafinil showed significant curative and therapeutic effects by regulating SNIP1 level.
Insights
Modafinil demonstrates significant therapeutic effects against acute pancreatitis (AP) by reducing inflammation, oxidative stress, and apoptosis. This action is mediated through the regulation of SNIP1 levels, offering a potential new treatment for AP.
Area of Science:
- Gastroenterology
- Pharmacology
- Molecular Biology
Background:
- Acute pancreatitis (AP) is a severe inflammatory condition of the pancreas.
- Modafinil exhibits known anti-inflammatory and anti-oxidative properties.
- The therapeutic potential of modafinil in AP has not been previously investigated.
Purpose of the Study:
- To investigate the therapeutic effects of modafinil on acute pancreatitis in vivo and in vitro.
- To elucidate the underlying molecular mechanisms of modafinil's action in AP.
- To assess modafinil's impact on pancreatic inflammation, oxidative stress, and apoptosis.
Main Methods:
- An in vivo rat model of AP was established using sodium taurocholate injection.
- In vitro AP models were created using AR42J cells stimulated with cerulein and lipopolysaccharide.
- Assays included HE staining, serum amylase/lipase, ELISA, MDA/SOD kits, TUNEL staining, Western blotting, qPCR, and flow cytometry.
- SNIP1 gene silencing was employed to explore modafinil's mechanism.
Main Results:
- Modafinil treatment significantly alleviated AP severity, reducing inflammation, oxidative stress, and apoptosis in the rat model.
- In vitro studies confirmed modafinil's protective effects against AP-induced cellular damage.
- Silencing SNIP1 reversed the beneficial effects of modafinil, indicating SNIP1's crucial role.
Conclusions:
- Modafinil possesses significant curative and therapeutic effects for acute pancreatitis.
- Modafinil exerts its protective effects by regulating SNIP1 expression.
- These findings suggest modafinil as a potential therapeutic agent for managing AP.
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pancreatitis II: Clinical Manifestations and Management

